OIMU
PFE icon

Osmosis Investment Management UK’s Pfizer PFE Stock Holding History

Osmosis Investment Management UK’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$719K Buy
29,844
+833
+3% +$21.8K 0.03% 309
2026
Q1 		$815K Buy
+29,011
New +$772K 0.02% 343

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Osmosis Investment Management UK's PFE Position: Q2 2026 in Review

Osmosis Investment Management UK increased its Pfizer (PFE) stake by 2.9% in Q2 2026, buying an estimated $21.8K and bringing the position to 29,844 shares worth $719K. The position accounts for 0.03% of the portfolio, ranked #309.

Osmosis Investment Management UK first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. The position peaked at $815K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Osmosis Investment Management UK held 29,844 shares of Pfizer worth $719K as of Q2 2026.
  • Osmosis Investment Management UK bought 833 Pfizer shares in Q2 2026, an estimated $21.8K.
  • Pfizer made up 0.03% of Osmosis Investment Management UK's portfolio in Q2 2026, its #309 holding.
  • Osmosis Investment Management UK first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
  • Osmosis Investment Management UK's Pfizer position peaked at $815K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Osmosis Investment Management UK's 13F filing for Q2 2026, filed 13 Aug 2026.